Summary & Overview

HCPCS Level II J7629: Bitolterol Inhalation Solution, Compounded Unit-Dose

HCPCS Level II code J7629 designates bitolterol mesylate inhalation solution as a compounded, unit-dose product administered through durable medical equipment (DME) and billed per milligram. The code matters nationally because it identifies a specific inhalation drug formulation and delivery method that affects billing, DME coordination, and pharmacy compounding practices for respiratory therapies.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for nebulized bronchodilator therapy, how this HCPCS Level II code is used in service lines involving DME, and the typical sites of service where the code applies. The publication summarizes billing benchmarks, coding considerations related to compounded inhalation products, and common payer coverage patterns and policy updates impacting billing and reimbursement for unit-dose nebulized drugs.

The report is organized to give clinicians, billing professionals, and policy analysts a clear reference on when J7629 is applicable, how it interacts with DME provision, and what documentation and coding elements are most relevant for national payer interactions. Data limitations: Data not available in the input.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareJ7629HCPCS Level IIinhalation solutionbitolteroldurable medical equipmentcompounded medicationunit-dosenebulizer

Billing Code Overview

HCPCS Level II code J7629 represents bitolterol mesylate, inhalation solution, compounded product, administered through durable medical equipment (DME), unit dose form, billed per milligram. This code describes a compounded bronchodilator inhalation medication prepared in unit-dose form for administration via DME such as nebulizers.

Service type: Drug administration (inhalation solution) via durable medical equipment

Typical site of service: Home or outpatient settings where DME nebulizer devices are used; could also include clinic-based nebulizer administration when DME is furnished for use

Clinical & Coding Specifications

Clinical Context

A typical patient is an adult with acute bronchospasm related to reversible obstructive airway disease (for example, acute exacerbation of asthma or chronic obstructive pulmonary disease with an acute bronchospastic component) who requires nebulized short-acting beta-agonist therapy delivered via durable medical equipment. The compounded inhalation solution J7629 (bitolterol mesylate, unit dose per mg) is prepared by the pharmacy, dispensed in unit-dose vials, and administered at the point of care through the patient’s home nebulizer or in an outpatient infusion/respiratory clinic using DME. Clinical workflow: a prescribing clinician documents the indication and dosage in the medical record, the pharmacy compounds and labels the unit-dose solution, DME staff supply the nebulizer and accessories if needed, a respiratory therapist or nursing staff instructs the patient on administration and documents the administration in the chart, and billing is submitted using J7629 with appropriate modifiers reflecting service circumstances (for example, family or multiple-payor billing modifiers, or modifiers indicating service discontinuation or unusual services). Typical sites of service include the patient’s home (home health or DME delivery), outpatient respiratory clinics, emergency departments, and skilled nursing facilities where DME nebulizer administration is supported.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier (used in some systems to indicate no modifier)	Rarely used; only when payer systems require a placeholder modifier indicating no special condition.
`22`	Increased procedural services	When the preparation or administration requires substantially greater physician or facility resources than typical (rare for unit-dose inhalation solution but applicable if extraordinary compounding or clinical supervision occurs).
`23`	Unusual anesthesia	Not commonly applied to inhalation solutions; would be used only if unusual anesthesia services are reported in the same encounter.
`52`	Reduced services	When the compound or administration was partially reduced or abbreviated compared to standard service.
`53`	Discontinued procedure	When therapy was started but discontinued due to patient intolerance or adverse reaction prior to completion of planned administration.
`54`	Surgical care only	Not typical for medication administration; not usually applicable to `J7629`.
`55`	Postoperative care only	Not typical for this service; not usually applicable.
`56`	Preoperative care only	Not typical for this service; not usually applicable.
`62`	Two surgeons	Not applicable to medication administration; included only if applicable in rare multidisciplinary procedural encounters.
`AS`	Physician assistant, nurse practitioner, or clinical nurse specialist services for Medicare beneficiaries	Use when a qualifying non-physician practitioner performed the service under applicable rules for the payer.
`CO`	Cast/orthopedic appliance (payer-specific use)	Unrelated to this drug code; only included by payers with specific business rules.
`CQ`	Service furnished by a clinical psychologist	Not applicable to medication administration; included only if reporting provider type is required by payer.
`FX`	Special modifier used by certain payers for claims processing	Use only per payer-specific instructions when required to indicate a special processing condition.
`QX`	Nurse practitioner rendering services (reimbursement modifiers vary)	Use when a nurse practitioner performs the service and payer requires this modifier for reimbursement.

Taxonomy Code	Specialty	Notes
`367A00000X`	Pulmonology	Common specialty ordering and overseeing inhaled bronchodilator therapy and respiratory DME.
`363L00000X`	Allergy & Immunology	Often manages asthma and may prescribe inhaled bronchodilators; involved in acute bronchospasm management.
`208D00000X`	Emergency Medicine	Frequently treats acute bronchospasm in the ED and documents need for nebulized therapy.
`345600000X`	Home Health Agency	Provides in-home administration, DME setup, and monitoring of nebulized medication.
`352P00000X`	Respiratory Therapy	Respiratory therapists administer nebulized medications, educate patients, and document treatment responses.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`J45.901`	Unspecified asthma, uncomplicated	Asthma exacerbations cause bronchospasm treated with short-acting inhaled bronchodilators such as bitolterol solution.
`J44.1`	Chronic obstructive pulmonary disease with (acute) exacerbation	Acute COPD exacerbations with bronchospasm often require nebulized short-acting bronchodilator therapy.
`J96.00`	Acute respiratory failure, unspecified whether with hypoxia or hypercapnia	Severe bronchospasm may progress to respiratory failure; nebulized bronchodilators are part of emergent management.
`R06.2`	Wheezing	Symptom code associated with bronchospasm and an indication for nebulized bronchodilator treatment.
`J98.01`	Acute bronchospasm	Direct diagnosis indicating need for short-acting inhaled bronchodilator therapy administered via nebulizer.
`J45.21`	Mild intermittent asthma with status asthmaticus	Status asthmaticus requires intensive bronchodilator therapy; unit-dose nebulized preparations may be used in treatment.
`Z79.82`	Long term (current) use of inhaled steroids	Comorbidity indicating chronic airway disease where short-acting nebulized bronchodilators are used as rescue therapy.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`94640`	Pressurized or non-pressurized inhalation treatment for acute airway obstruction; e.g., nebulizer therapy	Commonly billed for the professional service of administering nebulized bronchodilator therapy in clinic or ED when documentation supports a distinct inhalation treatment.
`94664`	Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device	Performed when a respiratory therapist or clinician instructs the patient on correct nebulizer device use when dispensing `J7629` for home administration.
`99070`	Supplies and materials provided by the physician over and above those usually included with the service (e.g., additional DME supplies)	May be used for ancillary supplies provided during an office visit in support of nebulized therapy, subject to payer rules.
`94002`	Ventilation assist and management, initiation of pressure or volume preset ventilator for assisted or controlled breathing; hospital inpatient/observation (separate procedure)	Relevant in severe respiratory distress where nebulized bronchodilator administration occurs in conjunction with ventilatory support; used when ventilator management is separately reportable.
`A9900`	Miscellaneous DME supply, accessory, or service component of another HCPCS code	Used by some payers to report DME-related supplies when specific HCPCS codes are not available; may be relevant when billing for DME-related items accompanying `J7629`.